Porphozym in the Treatment of Acute Attacks in AIP
A Multi-centre, Double-blind, Randomized, Placebo-controlled, Parallel Group Trial, Investigating the Efficacy and Safety of Porphozym (Recombinant Human Porphobilinogen Deaminase) in the Treatment of Acute Attacks in AIP A Multi-centre, Double-blind, Randomized, Placebo-controlled, Parallel Group Trial, Investigating th ...
Acute Intermittent Porphyria
Drug: recombinant human porphobilinogen deaminase (Porphozym)